STEPHANIE JOHNSON: Open Payments
NPI 1841844685 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,069 in 85 payments from 10 companies in 2025. Trend: 2023 $1,744 · 2024 $2,725 · 2025 $2,069
Food & beverage: $2,069
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 23 | $576 |
| Gilead Sciences, Inc. | 14 | $550 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 26 | $451 |
| Ipsen Biopharmaceuticals, Inc | 7 | $147 |
| ABBVIE INC. | 7 | $137 |
| ORPHALAN INC | 4 | $114 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Fujifilm Healthcare Americas Corporation | 1 | $23 |
| Intercept Pharmaceuticals, Inc. | 1 | $14 |
Products named: REZDIFFRA, XIFAXAN, IQIRVO, CUVRIOR, MAVYRET, CREON, LIVTENCITY, UTASWAKO AFP-L3.
Industry payments across TX — which companies pay providers there.
